Kura Oncology (NASDAQ: KURA) reported Q1 EPS of ($0.83), in-line with the analyst estimate of ($0.83). Revenue for the quarter came in at $18.27 million versus the consensus estimate of $25.4 million.

For earnings history and earnings-related data on Kura Oncology (KURA) click here.